Regulatory Considerations for Companion Diagnostics to Guarantee Commercialization
Time: 2:40 pm
day: Day 1 Track C PM
Details:
- Evolving regulatory climate and need to adapt with focus on EU IVD regulations
- Considerations for biomarker-driven clinical trials
- Considerations for global registration of companion diagnostics
- Regulatory perspective of strategies for a successful companion diagnostic program
